Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Knowledge Base
  • CellCountingSection
  • AAV Vector Transduction Efficiencies
Cell Counting and Image Cytometry

AAV Vector Transduction Efficiencies

Section
Cell-based Assays for Gene Therapy Development
Celigo Applications
Cell Counting Method Selection
Cell Counting and Image Cytometry FAQs
Cell-based Assays for Bioprocessing
Cell-based Assays for Gene Therapy Development
Cellometer Applications
Modern Virology Assays
Sub Section
AAV Vector Transduction Efficiencies
AAV Vector Design
AAV Vector Transduction Efficiencies
FDA Approval for Gene Therapy
Neutralizing Antibody Screening
Topic
Select an option
Direct Measurement Of Lentiviral Dose-Dependent Transduction Efficiencies Using GFP Fluorescence
Kinetic Measurement of AAV Vector Transduction Efficiencies To Optimize Assay Duration
Rapidly Determine the Multiplicity of Infection (MOI) Dependent AAV Vector Transduction Efficiencies to Optimize AAV Vector Design

Determination of AAV vector transduction efficiencies using an image-based direct cell analyzation method

In mammalian cells, DNA is wound around histones and locked away in the nucleus. The most advantageous keys that fit those locks and facilitate nuclear access are found on viruses. The three types of viral vectors most commonly used in the development of gene therapy products are adeno-associated virus (AAVs, 50%), adenovirus (12%), and lentivirus 11%). The effective viral vector transduction and transgene expression in a specific target cell type is a critical early step in the development process.

Multiple AAV serotypes preferentially infect different cell types. The table below (Table 1) shows which serotypes are best in specific tissues. AAV2 is the most studied. It is also possible to mix and match features of different serotypes. For example, taking a capsid from AAV3 and genome from AAV4 would be denoted as AAV3/4. Developing pseudotyped viruses can change vector tropism or which cell type it infects and can also improve transduction efficiency.
 

Optimal serotypes for specific tissues
Tissue AAV1 AAV2 AAV3 AAV4 AAV5 AAV6 AAV7 AAV8 AAV9
CNS x x   x x     x x
Heart x             x x
Kidney   x              
Liver             x x x
Lung       x x x     x
Pancreas               x  
Photoreceptor cells   x     x     x  
Retinal pigment epithelium x x   x x     x  
Skeletal muscle x         x x x x

 

Table 1. Optimal serotypes for specific tissues

Image cytometry enables fluorescence-based, direct cell counting methods to rapidly measure AAV vector transduction efficiencies

The Celigo™ Image Cytometer is a plate-based high-throughput system that simultaneously images and directly analyzes cells in standard multi-well plates using brightfield and fluorescence. The Celigo rapidly measures AAV vector transduction efficiencies for the optimization of an AAV vector design.

  1. Image and analyze 96- and 384-well plates in fluorescence in less than ten minutes per plate
  2. Direct cell counting method to determine transduction efficiencies using brightfield and fluorescent imaging
  3. Simultaneously measure transduction efficiencies and fluorescence intensities to quantitatively monitor expression levels


For research use only. Not for use in diagnostic procedures.

ON THIS PAGE
  • Determination of AAV vector transduction efficiencies using an image-based direct cell analyzation method
  • Image cytometry enables fluorescence-based, direct cell counting methods to rapidly measure AAV vector transduction efficiencies
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.